Colonic Stent and Tumor Cell Dissemination
Impact of Metallic Stent Insertion for Obstructing Colorectal Cancer on Circulating Tumor Cell Dissemination
1 other identifier
observational
40
0 countries
N/A
Brief Summary
This study aims to examine the hypothesis of tumor cell dissemination after colonic stenting for obstructing colorectal cancer by measuring the level of plasma circulating tumor cell before and after the procedure of successful colonic stenting in patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2010
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2012
CompletedFirst Submitted
Initial submission to the registry
June 21, 2012
CompletedFirst Posted
Study publicly available on registry
June 26, 2012
CompletedJune 26, 2012
June 1, 2012
1.4 years
June 21, 2012
June 21, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes of circulating tumor cell level before and after colonic stenting for patients with obstructive colorectal cancer
The patients' peripheral blood will be collected before and on first 3 days after the procedure.
Before and first 3 days after procedure
Study Arms (2)
Stenting
patient who received colonic stenting for obstructive colorectal cancer
Control
patients who had only colonoscopy without obstruction and without stenting
Eligibility Criteria
The study plan to recruit 20-30 patients in the stenting group and about 10-20 patients in the control groups. There is no previous study on this topic and hence, no information availabe for statistical analysis of sample size required to show a difference.
You may qualify if:
- Colonic stenting group
- Patients with obstructive colorectal cancer that requires colonic stenting as treatment
- Age \> 18 years and is able to give informed consent
- Informed consent for blood collection obtained
- Control group
- Patients with colorectal cancer who have colonoscopy without stenting
- Age \> 18 years and is able to give informed consent
- Informed consent for blood collection obtained
You may not qualify if:
- Patients who refuse or who is unable to give informed consent on blood taking for the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jensen TC Poon, MS
Department of Surgery, University of Hong Kong
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 21, 2012
First Posted
June 26, 2012
Study Start
July 1, 2010
Primary Completion
December 1, 2011
Study Completion
January 1, 2012
Last Updated
June 26, 2012
Record last verified: 2012-06